Paper593972
Soluble biomedical polymers.
Kopecek J. Polim Med, 1977. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Soluble biomedical polymers. Papers, record 593972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/593972
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Polymers | Major topic |
| Anti-Bacterial Agents | |
| Antitubercular Agents | |
| Biocompatible Materials | |
| Chemical Phenomena | |
| Chemistry | |
| Humans | |
| Solubility |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38734315 | Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics. | J Control Release | 2024 | https://conductscience.org/library/papers/38734315 | PubMed |
| 37849670 | Encapsulation of Ru(II) Polypyridine Complexes for Tumor-Targeted Anticancer Therapy. | BME Front | 2023 | https://conductscience.org/library/papers/37849670 | PubMed |
| 32735811 | Polymer nanomedicines. | Adv Drug Deliv Rev | 2020 | https://conductscience.org/library/papers/32735811 | PubMed |
| 29966420 | Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis. | Mol Pharm | 2018 | https://conductscience.org/library/papers/29966420 | PubMed |
| 29313017 | Anticancer nanoparticulate polymer-drug conjugate. | Bioeng Transl Med | 2016 | https://conductscience.org/library/papers/29313017 | PubMed |
| 29276426 | The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment. | Curr Opin Colloid Interface Sci | 2017 | https://conductscience.org/library/papers/29276426 | PubMed |
| 28830983 | HPMA-Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer. | Mol Cancer Ther | 2017 | https://conductscience.org/library/papers/28830983 | PubMed |
| 28094954 | Backbone Degradable N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts. | Mol Pharm | 2017 | https://conductscience.org/library/papers/28094954 | PubMed |
| 26688694 | POLYMERIC BIOMATERIALS AND NANOMEDICINES. | J Drug Deliv Sci Technol | 2015 | https://conductscience.org/library/papers/26688694 | PubMed |
| 26437260 | Design of smart HPMA copolymer-based nanomedicines. | J Control Release | 2016 | https://conductscience.org/library/papers/26437260 | PubMed |
| 26191406 | Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines. | Biomater Sci | 2015 | https://conductscience.org/library/papers/26191406 | PubMed |
| 25709446 | Nanopharmaceuticals (part 2): products in the pipeline. | Int J Nanomedicine | 2015 | https://conductscience.org/library/papers/25709446 | PubMed |
| 24747162 | Macromolecular therapeutics. | J Control Release | 2014 | https://conductscience.org/library/papers/24747162 | PubMed |
| 23827653 | Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment. | Int J Pharm | 2013 | https://conductscience.org/library/papers/23827653 | PubMed |
| 23731780 | Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats. | Biomaterials | 2013 | https://conductscience.org/library/papers/23731780 | PubMed |
| 23339052 | Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy. | Macromol Biosci | 2013 | https://conductscience.org/library/papers/23339052 | PubMed |
| 23123294 | Polymer-drug conjugates: origins, progress to date and future directions. | Adv Drug Deliv Rev | 2013 | https://conductscience.org/library/papers/23123294 | PubMed |
| 22493797 | Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates. | Macromol Biosci | 2012 | https://conductscience.org/library/papers/22493797 | PubMed |
| 22288884 | Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates. | Biomacromolecules | 2012 | https://conductscience.org/library/papers/22288884 | PubMed |
| 21499527 | Synthesis of Biodegradable Multiblock Copolymers by Click Coupling of RAFT-Generated HeterotelechelicPolyHPMA Conjugates. | React Funct Polym | 2011 | https://conductscience.org/library/papers/21499527 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/593972
GET https://conductscience.org/api/papers/v1/593972/cited_by?page=2